Previous Article | Next Article 
Journal of Clinical Microbiology, November 1998, p. 3297-3302, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Genetic Heterogeneity of Clinical Strains of Yersinia
enterocolitica Traced by Ribotyping and Relationships between
Ribotypes, Serotypes, and Biotypes
M. J.
Lobato,1
E.
Landeras,1
M. A.
González-Hevia,2 and
M. C.
Mendoza1,*
Departamento de Biología Funcional,
Area Microbiología, Facultad de Medicina, Universidad de
Oviedo, 33006-Oviedo,1 and
Laboratorio
de Salud Pública, Consejería de Servicios Sociales
del Principado de Asturias, 33011-Oviedo,2 Spain
Received 26 May 1998/Returned for modification 7 July 1998/Accepted 28 July 1998
 |
ABSTRACT |
A series of 74 Yersinia enterocolitica clinical strains
collected in a Spanish region and 10 reference strains, assigned to nine serotypes and five biotypes, were analyzed by ribotyping procedures. Riboprobing, performed separately with HindIII
and BglI and using an rrn operon as the probe,
generated 13 and 11 ribotypes (discrimination index [DI] = 0.56 and 0.55), respectively. PCR ribotyping, performed with primers
complementary to conserved regions of 16S and 23S rRNA genes, generated
13 ribotypes (DI = 0.56). A combination of data from the three
procedures allowed for further discrimination into 17 combined
ribotypes (DI = 0.83). The dendrogram obtained by cluster analysis
of data from riboprobing indicated a high heterogeneity of the
ribosomal DNA regions of the strains under study (similarities between
10 and 92%), which were grouped into three clusters at a similarity
level of 0.32. The major cluster included 10 branches, and 7 of these
formed a subcluster (similarity coefficient, >83%) represented by
strains of serotype O:3 and biotype 2, 3, or 4. The second cluster
included four branches, represented by strains belonging to seven
non-O:3 serotypes, biotypes 1A and 2, and two of these branches
included pyrazinamidase-positive as well as pyrazinamidase-negative
strains. The remaining three branches, represented by O:3-biotype 4 strains, formed a third cluster weakly related to the others. Data from this study showed that Y. enterocolitica O:3 organisms
assigned to a prevalent and endemic lineage and non-O:3 organisms
assigned to three other less-frequent lineages are circulating and
causing human disease in the Spanish region under study.
 |
INTRODUCTION |
Among the enteroinvasive bacteria
causing human infections is Yersinia enterocolitica, in
which virulence results from a complex interplay between a series of
chromosomal and plasmid-borne genes. It is associated mainly with
enterocolitis and, less frequently, with a wide variety of clinical and
immunologic manifestations (4, 6, 14). Although human
carriers are rare, animal carriers are frequent. Humans are infected
primarily by the ingestion of fecally contaminated food or water, and
over the past two decades an increase in cases of human infection with
Y. enterocolitica has been reported in many developed
countries (mainly in colder climates) (1, 2, 4, 8, 9, 14).
For epidemiological purposes intraspecies differentiation is usually
carried out by serotyping and biotyping, which have revealed that only
a few clones can be considered primary pathogens (2, 4, 8, 16). They also enable the placement of virulent clones into two
extensive groups, the American group (biotype 1B, mainly including serotypes O:8, O:13a, O:13b, O:20, and O:21) and the European group
(biotypes 2 to 5, mainly including serotypes O:3, O:5,27, and O:9).
However, over the last decade serotype O:3 has emerged as the most
frequent in some U.S. countries and states (2, 3). On the
other hand, biotype 1A, despite being considered nonpathogenic, has
constituted a sizable fraction of strains from patients with
enterocolitis in some studies (6, 14), and recently, several
other biotypes and serotypes traditionally considered nonpathogenic,
which were negative for virulence markers, have been associated with
human disease in the Republic of Georgia (15). Both the wide
dispersion of the two groups of virulent clones mentioned above and the
emergence of clones initially defined as nonvirulent support the use of
new epidemiological markers, preferably those that involve direct DNA
analysis of the chromosome. A good genetic marker must reveal a high
degree of polymorphism, which can be interpreted in terms of genetic
variation at specific chromosomal loci. Variation that is selectively
neutral and irrelevant to disease processes is best for assessing the
genetic relatedness of isolates (7, 17).
The purpose of this study was to explore genetic diversity among
contemporary Y. enterocolitica organisms, collected in four hospitals of a Spanish region (the Principality of Asturias), by
procedures that analyze the sequence divergence of the rrn loci, which encode the rRNAs. The rRNA genes are organized as polycistronic transcriptional units called rrn operons
(5'-promoter-16S-spacer region-23S-5S-3') and, together with
their flanking sequences, form the ribosomal DNA (rDNA) regions. While
the rRNA genes are highly conserved, the flanking sequences and the
intergenic spacer region (SR) between the 16S and 23S rRNA genes can
show a significant degree of variation in length and sequence within a
single species, and the differences can be used to discriminate clones
and clonal lineages (3, 5, 11-13). The procedures used in
this work were (i) analysis of restriction fragment length
polymorphisms of rDNA regions generated with two selected
restriction endonucleases, HindIII and
BglI, and Southern hybridization with an
rrn probe and (ii) amplification by PCR and
analysis of the SR by using oligonucleotide primers
complementary to conserved sequences of the 16S and 23S rRNA genes. The
former procedure is usually called ribotyping or riboprobing, and
the banding patterns are called ribotypes. The latter procedure is
termed PCR ribotyping, and the patterns of amplified fragments are
called SR ribotypes. Results from riboprobing and PCR ribotyping were
correlated, combined, and used to define combined ribotypes (CRTs), as
well as to trace the relationships between ribotypes and serotypes and
those between ribotypes and biotypes. In addition, the data were used
to ascertain the diversity of types and clonal lineages of Y. enterocolitica causing human disease that have been circulating in
the region under study.
 |
MATERIALS AND METHODS |
Bacterial strains.
This study included 84 strains of
Y. enterocolitica (see Table 1). Sixty-six strains were
collected from diarrheic human feces from patients attending four
Asturian hospitals over the period 1993 through 1995 and were
implicated in 66 apparently sporadic episodes of enterocolitis. In
fact, they were not associated with outbreaks occurring at different
times in different areas and places, and investigation into possible
vehicles of infection was not carried out. They represented about 34%
of yersiniosis episodes microbiologically diagnosed in these hospitals
during this 3-year period. Eight other strains were clinical Asturian strains collected before or during 1992, representing eight different clonal lines previously defined by ribotyping with five enzymes (12). The remaining 10 strains were from other collections, representing pathogenic and nonpathogenic biogroups, and were used as
reference strains.
Serotyping and biotyping.
Serotyping was performed on the
clinical isolates by the slide agglutination test with commercial
antisera for serotypes O:3, O:5, O:8, O:9, and O:1,2 (Denka Seiken Co.,
Ltd., Tokyo, Japan). Biotyping was performed according to the scheme of
Wauters et al. (16).
Chromosomal DNA isolation and ribotyping procedures.
Chromosomal DNA isolation and riboprobing using the restriction
endonucleases HindIII and BglI were carried
out as described in reference 12. The patterns of
bands containing rRNA gene sequences have been designated H ribotypes
and B ribotypes, respectively, and the polymorphic restriction sites
(PRSs) along the rDNA regions have been inferred by the presence or
absence of bands in the totality of ribotypes from each endonuclease.
PCR ribotyping was carried out basically as described in reference
11, with primers P1 (5'-TTGTACACACGCCCGTCA-3')
and P2 (5'-GGTACTTAGATGTTTCAGTTC-3'). It is noteworthy
that changes in the amplification conditions selected (35 cycles of 1 min at 94-95°C, 1 min at 55-56°C, and 1 to 2 min at 72°C) could
produce different amplified DNA band patterns. Minor differences in
band intensity were not considered to define SR ribotypes. All
preparations and runs were repeated at least three times to evaluate
the reproducibility of the method and to prove the stability of the SR
ribotypes. Strains showing identical ribotypes with the three
procedures were ascribed to the same CRT, and each of these was
labelled with a roman numeral (I to XVII) indicating the particular
combination between H and B ribotypes found. The roman numeral was
followed by an arabic numeral corresponding to the SR ribotype.
Statistical analyses.
The discrimination index (DI), i.e.,
the probability that two unrelated strains tested from the population
would be placed into different typing groups, was calculated by
Simpson's index of diversity (10). For the phylogenetic
analysis only riboprobing data were used, and a combined numerical
analysis of different banding profiles, revealed with each restriction
endonuclease, was performed with a software package as previously
described (12, 13).
 |
RESULTS |
In a first step, Y. enterocolitica organisms isolated
in Asturian hospitals were analyzed by serotyping and biotyping. They were differentiated into serotypes O:1,2, O:3, O:8, and O:9 (or classified as not agglutinating [NA] with the sera used), as well as
into biotypes 1A, 2, 3, and 4 (BT1A, BT2, BT3, and BT4) (Table 1). Strains assigned to O:3 belonged to
three biotypes: BT4 (56 strains, which produced DNAse but not
lipase or indole, reduced nitrate to nitrite, were Voges-Proskauer
positive, fermented sucrose and D-trehalose but not
D-xylose and salicin, did not hydrolyze esculin, and did
not show pyrazinamidase or
-D-glucosidase activity), BT2
(6 strains, which differed from BT4 strains in that they were xylose
and indole positive), and BT3 (4 strains that were xylose positive and
indole negative, in contrast to BT4 and BT2 strains). Six other strains
were NA; of these, three belonged to BT2 and the remaining three
to BT1A (differing from BT2 strains in that they were lipase, salicin,
esculin, and pyrazinamidase positive). Only one strain each was
assigned to the phenotypic groups O:1,2-BT2, O:8-BT2, and O:9-BT2.
These data showed that O:3 and NA clinical strains could be
differentiated into three (BT4, BT3, and BT2), and two (BT2 and BT1A)
biotypes, respectively. Conversely, BT2 included strains of
different serotypes (O:3, O:1,2, O:8, and O:9), as well as NA strains.
For the assays discussed below, 10 Y. enterocolitica
reference strains (Table 1), representing some of these phenotypic
groups and five others, were also included in the series.
When DNA samples were separately cleaved with HindIII
and BglI and were hybridized with the rnnB
probe, several ribotypes could be defined (Fig.
1 and 2).
With HindIII, 13 different H ribotypes were found
in the series, 11 of which were represented by Asturian clinical
strains and 8 of which were within serotype O:3. The H ribotypes
included 5 to 14 fragments that appeared in the region between 30 and
2.3 kb, and no fragments were common to all 13 H ribotypes. Ribotypes
H1 versus H7 and H7 versus H8 differed in the size of absence,
respectively, of a single fragment, whereas they showed several
fragments that are not present among the remaining H ribotypes.
Analysis of the uncommon fragments led to more than 52 PRSs. The H
ribotype of the single O:1,2a,3 strain (H23), as well as those of all
but two O:3 strains, was composed of seven or fewer fragments, which
were larger than 7 kb. Each of the remaining two O:3 strains showed a
different ribotype, H4 or H5, that included eight fragments. The H
ribotypes established could be visually clustered into two groupings,
one comprising H1, H6, H7, H8, and H23 and the other comprising H2, H3,
H4, and H5. On the other hand, the H ribotypes from strains assigned to other serotypes included 12 to 14 fragments, some smaller than 6 kb,
and formed a third visual grouping (H21, H22, H24, and H25).

View larger version (125K):
[in this window]
[in a new window]
|
FIG. 1.
Ribotypes generated by HindIII in
Y. enterocolitica strains of different serotypes and
biotypes. Lanes A to D and F to H, ribotypes shown only by O:3-BT4
strains. Lane E, ribotype shown by O:3-BT2, O:3-BT3, and O:3-BT4
strains. Lanes I and J, ribotypes shown by O:1,2a,3-BT3 and O:8-BT2
strains, respectively. Lane K, ribotype shown by O:1,2-BT2,
O:4,32-BT1Ax, O:5-BT1A, O:8-BT2, O:9-BT2, O:21-BT1Ax, and NA-BT1A
strains. Lanes L and M, ribotypes shown by O:13,7-BT1Ax and
NA-BT2 strains, respectively. Data for the clinical and reference
strains corresponding to each H ribotype are presented in Table
1.
|
|

View larger version (127K):
[in this window]
[in a new window]
|
FIG. 2.
Ribotypes generated by BglI in Y. enterocolitica strains of different serotypes and biotypes. Lane
A, ribotype shown by O:3-BT2, O:3-BT3, and O:3-BT4 strains. Lanes B
to F, ribotypes shown only by O:3-BT4 strains. Lane G, ribotype shown
by O:1,2-BT2, O:5-BT1A, NA-BT1A, and NA-BT2 strains. Lane H,
ribotype shown by O:4,32-BT1Ax, O:8-BT2, O:9-BT2, O:13,7-BT1Ax, and
O:21-BT1Ax strains. Lanes I to K, ribotypes shown by O:1,2a,3-BT3,
O:8-BT2, and NA-BT2 strains, respectively. Data for the clinical and
reference strains corresponding each B ribotype are presented in Table
1.
|
|
With BglI, 11 B ribotypes were found in the series, 10 among
the Asturian clinical isolates, and 6 within serotype O:3. The B
ribotypes included 10 to 14 fragments along the 14.2- to 1.7-kb region
and showed at least 54 PRSs in total. The most frequent ribotype, B1,
differed from two other frequent ribotypes, B4 and B6, only in the
presence (B4) or absence (B6) of one fragment. All three were
found only among O:3 strains. Two other ribotypes, B21 and B25,
found among O:1,2, O:5, and NA strains and among O:4,32, O:8,
O:9, O:13,7, and O:21 strains, respectively, differed only in two
fragments, whereas differences between other B ribotypes affected a
higher number of fragments. B ribotypes could be visually clustered
into three groupings, two (B1, B4, and B6 and B2, B3, and B5) found
only among O:3 organisms and one (B21 to B25) found only among non-O:3
organisms. Despite the relationship between visual grouping and
serotype, the B ribotypes falling into the first and the third grouping
have more similarities with each other than with members of the second
grouping.
By PCR ribotyping, 13 specific SR ribotypes have been found in
the series, 11 among the Asturian clinical strains and 7 among O:3 strains (Fig. 3; Table 1). The SR
ribotypes included two to seven well-defined amplified DNA
fragments, some stronger than others, but all constant and reproducible
under our assay conditions. Some SR ribotype pairs showed one or more
common fragments (i.e., SR1 and SR4; SR23 and SR24), but none of the
fragments was common to all 13 SR ribotypes. Frequently, weak
additional fragments appeared, but they have not been considered here,
since we assumed that they had been generated by nonspecific DNA
amplification. SR1, defined by only two very closely situated
fragments, was the most frequent SR ribotype (59.5% of the series) and
appeared among strains assigned to nine H and seven B ribotypes.
SR2, SR25, and SR26 each appeared in strains assigned to two different
B or H ribotypes, while the remaining SR ribotypes each appeared only
in strains assigned to a single, specific H, B, or combined ribotype (Table 1).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 3.
Ribotypes generated by PCR amplification using primers
for conserved regions of 16S and 23S rRNA genes in Y. enterocolitica. Lane A, ribotype shown by O:3-BT2, O:3-BT3,
O:3-BT4, O:1,2a,3-BT3, and O:8-BT2 strains. Lane B, ribotype shown
by O:3-BT2, O:3-BT3, and O:3-BT4 strains. Lane C, ribotype shown by
O:3-BT2 and O:3-BT3 strains. Lanes D, E, and G, ribotype shown by
O:3-BT4 strains. Lane F, ribotype shown by one O:3-BT3 strain. Lane
H, ribotype shown by O:1,2-BT2 and NA-BT1A strains. Lane I, NA-BT1A
and NA-BT2 strains. Lane J, ribotype shown by one NA-BT2 strain. Lane
K, ribotype shown by O:9-BT2 strains. Lane L, ribotype shown by
O:8-BT2 and O:13,7-BT1Ax strains. Lane M, ribotype shown by
O:4,32-BT1Ax and O:21-BT1Ax strains. Lanes P, DNA of phage lambda
cleaved with PstI. Data for the clinical and reference
strains corresponding to each ribotype are presented in Table 1.
|
|
When data from HindIII riboprobing, BglI
riboprobing, and PCR ribotyping were compared, a different distribution
of strains into types was noted. Thus, strains falling into the most
frequent types by a given procedure were differentiated by
the two other procedures. Combination of the H and B
ribotypes differentiated the series into 17 groups (labelled CRTI
to CRTXVII). The addition of SR ribotypes increased the number to 27, because four of the groups were further differentiated (into CRTI-1 to
-6; CRTII-1 and -2; CRTXII-21, -22, and -26; and CRTXIII-24 to -26)
(Table 1).
The analysis of the relationships between genotypic and phenotypic
markers revealed that in the series, each ribotype was associated with
a specific serotype, with the following exceptions: ribotypes H21, B21,
and B25 were represented by strains assigned to several infrequent
serotypes (O:1,2, O:4,32, O:5, O:8, O:9, O:21, and NA for H21; O:1,2,
O:5, and NA for B21; O:8, O:9, O:13,7, O:21, and O:4,32 for B25). SR1
was represented by 48 strains assigned to three serotypes: O:3 (45 strains), O:8 (2 strains), and O:1,2a,3 (1 strain). Three other
ribotypes, SR21, SR25, and SR26, included strains of different and
infrequent serotypes (O:1,2 and NA for SR21; O:8 and O:13,7 for SR25;
and O:5, O:21, and O:4,32 for SR26). Four frequent CRTs (CRTI-1 to -3;
CRTIII) were represented only by O:3 strains assigned to BT4, BT3,
and/or BT2, the only biochemical difference between them being indole
production and/or xylose fermentation. Similarly, CRTXII-22 was
represented by four NA strains assigned to two different biotypes, BT1A
and BT2. In the series, one phenotypic group (O:3-BT4) was prevalent
(58 strains; 68.23%); it was subdivided into 8 H ribotypes, 6 B
ribotypes, and 7 SR ribotypes, and, by combining data from three
procedures, it comprised 17 CRTs or genomic groups. On the other hand,
clinical and reference strains expressing biochemical traits not
associated with virulence (such as pyrazinamidase activity, esculin
hydrolysis, and salicin fermentation) and differing in serotype
(O:4,32, O:5, O:13,7, O:21, and NA) and indole production (positive
[BT1A] and negative [BT1Ax]) had identical (or not very different)
ribotypes. These were also identical to, or not very different from,
the ribotypes of strains that did not have these traits, all of which were assigned to BT2 but to different serotypes (O:1,2, O:8, O:9, and
NA).
For epidemiological purposes the discrimination power of the typing
procedures is very important, and this was tested by two different
parameters: the number of types generated with each procedure (see
discussion above) and the calculation of a DI. The DI values were 0.56, 0.55, and 0.56 for HindIII, BglI, and PCR
ribotyping, respectively. The increase in the discrimination power
resulting from the combination of data from two or three ribotyping
procedures was also calculated, for HindIII and
BglI (17 types; DI = 0.67), HindIII and
PCR (22 types; DI = 0.76), BglI and PCR (21 types;
DI = 0.74), and HindIII, BglI, and PCR (26 types; DI = 0.83). When data from serotyping and biotyping were added, the series was differentiated into 36 groupings or subtypes
(DI = 0.86). With the last two options, the 74 Asturian clinical
strains were differentiated into 15 CRTs and 30 subtypes, respectively.
Data from the ribotypes generated with HindIII and
BglI were used to trace a similarity dendrogram which showed
a high heterogeneity of rDNA regions of the strains under study
(similarity between 10 and 98%) and demonstrated that different
groupings could be observed at varying levels of similarity (Fig.
4). At a low level (similarity
coefficient [S] = 0.32), the strains were distributed into three
clusters (A, B, and C), whereas at a high level (S = 0.83), each
cluster could be differentiated into a subcluster and one or more
branches. Cluster A groups 10 branches comprising strains assigned to
16 CRTs, 4 serotypes, and 3 biotypes. Seven of these branches showed
similarities higher than 83%, forming the subcluster Aa, which
includes only O:3 strains. Cluster B groups four branches,
corresponding to seven CRTs and eight non-O:3 serotypes. It is
worthy of note that three of these branches form subcluster Bb,
which includes clinical and reference strains assigned to
serotypes O:1,2, O:4,32, O:5, O:8, O:9, O:13,7, O:21, and NA, as
well as BT1A, BT1Ax, and BT2. Cluster C includes three branches, each
corresponding to a single CRT and a single O:3-BT4 clinical strain.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 4.
Dendrogram obtained from cluster analysis of
HindIII and BglI ribotypes of Y. enterocolitica strains by using the Multivariate Statistics
Package 2.0a and drawn with KOREL 5.0. A, B, and C and Aa, Bb, and Cc
are the clusters and subclusters revealed at similarity coefficients of
0.32 and 0.82, respectively. The CRTs, serotypes, and biotypes falling
into each branch are given. Other features and the numbers of strains
falling into each branch and cluster are shown in Table 1 and discussed
in the text.
|
|
 |
DISCUSSION |
The usefulness of a trait for typing is related to its stability
in a given strain and its diversity among the strains forming one
species. Both criteria are fulfilled by the trait analyzed by
ribotyping procedures: the rrn operons. In the present
work, three ribotyping variants, alone and in combination, were
evaluated for Y. enterocolitica typing, and the
combination of the three was used to investigate the genetic diversity
of a series of Y. enterocolitica clinical and
reference strains. In all but three of the O:3 strains tested by
HindIII riboprobing in our laboratories (reference
12 and the present work), the H ribotypes included seven or fewer bands, which were larger than 7.5 kb. The three remaining strains showed H ribotypes with eight bands. Our data support
the fact that O:3 strains usually have no HindIII
cutting points within the rnn operons and that each band
usually carries only one rnn operon, although in H
ribotypes with fewer than seven bands, some fragments could carry
two neighboring rrn operons or, alternatively, could
correspond to two different DNA fragments of similar size. On the other
hand, all H ribotypes found among strains that did not agglutinate with
O:3 serum included 12 or more bands, data supporting the presence of
HindIII cutting points within some or all of the
rrn operons. Results obtained with BglI could be
interpreted in a similar way, since in all the strains tested this
enzyme generated ribotypes with 10 or more bands, several of which were
smaller than 6.4 kb. This indicates the presence of one or more
BglI sites within some or all of the rnn operons.
In the strains under study, riboprobing performed with both
endonucleases revealed a high level of sequence divergence among the
rDNA regions. However, divergences affecting the size of the 16S-23S
rRNA SRs were efficiently revealed by PCR ribotyping. The most notable
example was that the strains showing H1-B1 ribotypes (grouped as CRTI)
were differentiated into six SR ribotypes (CRTI-1 to -6).
Due to its reproducibility in distributing strains into SR ribotypes,
PCR ribotyping has revealed itself as a highly adequate tool for
epidemiological purposes, differentiating strains assigned to the most
frequent phenotypic groups and also to the most frequent H and B
ribotypes. Although in different experiments the amplified profile of a
given strain could include one or more bands that were poorly defined
or were not always revealed, the profile was still different from those
corresponding to other SR ribotypes. In addition, differences in the
sizes of certain bands were very slight and did not permit an accurate
visual differentiation of common and noncommon bands in the totality of
SR ribotypes. Taking both shortcomings into account, we decided to
exclude data from PCR ribotyping for tracing the dendrogram of
similarity among combined ribotypes. Cluster analysis of data from H
and B ribotypes has shown that the Y. enterocolitica strains under study are probably members of
different lineages, some of which include strains assigned to different
serotypes and/or biotypes. For instance, in the dendrogram some
O:3-BT4 strains were separated by a considerable genetic distances,
falling into two different clusters. Conversely, clinical and reference
strains assigned to different phenotypic groups (non-O:3, non-BT4)
yielded identical or not very different ribotypes, forming a
subcluster categorized as a single clonal lineage which included both
pyrazinamidase-positive and pyrazinamidase-negative strains. The
relationships between biotypes and lineages found in the series under
study are only partially in line with the relationships among biotypes
revealed by multilocus enzyme electrophoresis in other Y. enterocolitica series (7).
The above-mentioned data also led to an increase in our knowledge of
the contemporary molecular epidemiology of human yersiniosis in the
Principality of Asturias. In this respect, the findings to be
emphasized are the following. (i) Ribotyping procedures are
useful tools for differentiating individual clinical strains of
Y. enterocolitica, as well as for grouping strains with
ribotypes that are not very different from each other into clonal
lineages and for revealing a high degree of heterogeneity within the
rDNA regions of these strains. (ii) Clinical strains collected between 1993 and 1995 were assigned to 18 CRTs, 6 of which could be
differentiated by serotyping and/or biotyping. Among these strains, all
those assigned to O:3-BT2, O:3-BT3, and O:3-BT4 showed CRTs falling into a single lineage, which can be considered prevalent and endemic because it groups organisms collected over a 12-year period (1984 to
1995) from patients attending four different hospitals sited in an area
of about 10,565 km2 with 1,120,000 inhabitants. Some of
these CRTs were also shown by O:3-BT4 organisms collected from
commercial raw meat products (reference 12 and
unpublished data). (iii) Three other CRTs, represented only by O:3-BT4
clinical strains, formed a different lineage, showing a low level of
similarity with the CRTs included in the prevalent lineage. These CRTs
were infrequently found among strains collected before or during 1992 (reference 12 and unpublished data) and were not
represented among strains collected after 1992. (iv) Non-O:3 clinical
strains were assigned to five infrequent genomic groups. Three of these
strains were BT1A, but their ribotypes were identical to ribotypes of
some BT2 clinical strains and were not very different from ribotypes of
reference strains representing BT1A, BT1Ax, and BT2. These three BT1A
strains were isolated in the same hospital in 1993. One, collected from
the feces of a woman, was the only bacterium that could be associated
with her acute abdominal pain; the other two were collected from the
diarrheic feces of two children, which carried an additional pathogenic species each (Salmonella and Campylobacter
species, respectively). It should be pointed out that in previous works
(6, 14), clinical evidence showed that some BT1A strains may
be adapted to human hosts and were found to be associated with the same
clinical symptoms as strains assigned to primary pathogenic biogroups.
All these data show that the polymorphism of the rDNA regions of
Y. enterocolitica can be revealed by different
ribotyping procedures, and they support the usefulness of CRTs as
genetic markers which can be used alone or in addition to
conventional phenotypic markers in epidemiological surveys of
yersiniosis.
 |
ACKNOWLEDGMENTS |
We thank M. Altwegg for plasmid pKK3535 and R. Díaz
(Faculty of Medicine of Navarra) and F. Uruburu of CECT for the
Y. enterocolitica reference strains. We thank the staff
of the Microbiology Laboratories of the Hospital Central de Asturias,
the Hospital San Agustín de Avilés, the Hospital de
Jarrio, the Hospital Cabueñes de Gijón, and the Hospital
Carmen and Severo Ochoa de Cangas del Narcea for the clinical isolates.
This work has been supported by grants from Oviedo University (Ref.
92/38) and the Fondo de Investigacion Sanitaria (Ref. 95/0030/01).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Area de
Microbiología, Facultad de Medicina, C/Julián
Clavería s/n, 33006-Oviedo, Spain. Phone: 34 985103560. Fax: 34-985103148. E-mail: camf{at}sauron.quimica.uniovi.es.
 |
REFERENCES |
| 1.
|
Andersen, J. K.,
R. Sorensen, and M. Glensbjerg.
1991.
Aspects of the epidemiology of Yersinia enterocolitica: a review.
Int. J. Food Microbiol.
13:231-238[Medline].
|
| 2.
|
Bisset, M. L.,
C. Powers,
S. L. Abbot, and J. M. Janda.
1990.
Epidemiologic investigations of Yersinia enterocolitica and related species: sources, frequency and serogroup distribution.
J. Clin. Microbiol.
28:910-912[Abstract/Free Full Text].
|
| 3.
|
Blumberg, H. M.,
J. A. Kiehlbauch, and I. K. Wachsmuth.
1991.
Molecular epidemiology of Yersinia enterocolitica O:3 infections: use of chromosomal DNA restriction fragment length polymorphisms of rRNA genes.
J. Clin. Microbiol.
29:2368-2374[Abstract/Free Full Text].
|
| 4.
|
Bottone, E. J.
1997.
Yersinia enterocolitica: the charisma continues.
Clin. Microbiol. Rev.
10:257-276[Abstract].
|
| 5.
|
Brosius, J.,
A. Ullrich,
M. A. Raker,
A. Gray,
T. J. Dull,
R. R. Gutell, and H. F. Noller.
1981.
Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli.
Plasmid
6:112-118[Medline].
|
| 6.
|
Burnens, A. P.,
A. Frey, and J. Nicolet.
1996.
Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease.
Epidemiol. Infect.
116:27-34[Medline].
|
| 7.
|
Dolina, M., and R. Peduzzi.
1993.
Population genetics of human, animal, and environmental Yersinia strains.
Appl. Environ. Microbiol.
59:442-450[Abstract/Free Full Text].
|
| 8.
|
Gómez-Garcés, J. L.,
I. Wilhelmi,
R. Cogollos,
J. I. Alós,
M. Páez,
D. Balas,
A. Arribi, and A. y Delgado-Iribarren.
1996.
Factores de patogenicidad, biotipo, serotipo y sensibilidad antimicrobiana de 150 aislamientos clínicos de Yersinia grupo enterocolitica (1992-1994).
Enferm. Infect. Microbiol. Clin.
14:596-599[Medline].
|
| 9.
|
Gonzalez-Hevia, M. A.,
J. A. Alvarez Riesgo, and M. C. Mendoza.
1990.
Epidemiological, clinical and microbiological features of Yersinia enterocolitica infections in a community during a four-year period.
Eur. J. Epidemiol.
6:184-190[Medline].
|
| 10.
|
Hunter, P. R., and M. A. Gaston.
1988.
Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.
J. Clin. Microbiol.
26:2465-2466[Abstract/Free Full Text].
|
| 11.
|
Kostman, J. R.,
T. D. Edlind,
J. J. LiPuma, and T. L. Stull.
1992.
Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping.
J. Clin. Microbiol.
30:2084-2087[Abstract/Free Full Text].
|
| 12.
|
Mendoza, M. C.,
R. Alzugaray,
E. Landeras, and M. A. González-Hevia.
1996.
Discriminatory power and application of ribotyping of Yersinia enterocolitica O:3 in an epidemiological study.
Eur. J. Clin. Microbiol. Infect. Dis.
15:220-226[Medline].
|
| 13.
|
Millemann, Y.,
M.-C. Lesage,
E. Chaslus-Dancla, and J.-P. Lafont.
1995.
Value of plasmid profiling, ribotyping, and detection of IS200 for tracing avian isolates of Salmonella typhimurium and S. enteritidis.
J. Clin. Microbiol.
33:173-179[Abstract].
|
| 14.
|
Morris, J. G., Jr.,
V. Prado,
C. Ferreccio,
R. M. Robins-Browne,
A.-M. Bordun,
M. Cayazzo,
B. A. Kay, and M. M. Levine.
1991.
Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors.
J. Clin. Microbiol.
29:2784-2788[Abstract/Free Full Text].
|
| 15.
|
Sulakvelidze, A.,
K. Dalakishvili,
E. Barry,
G. Wauters,
R. Robins-Browne,
P. Imnadze, and J. G. Morris, Jr.
1996.
Analysis of clinical and environmental Yersinia isolates in the Republic of Georgia.
J. Clin. Microbiol.
34:2325-2327[Abstract].
|
| 16.
|
Wauters, G.,
K. Kandolo, and M. Janssens.
1987.
Revised biogrouping scheme of Yersinia enterocolitica.
Contrib. Microbiol. Immunol.
9:14-21[Medline].
|
| 17.
|
Whittam, S. T.
1995.
Genetic population structure and pathogenicity in enteric bacteria.
Symp. Soc. Gen. Microbiol.
52:217-245.
|
Journal of Clinical Microbiology, November 1998, p. 3297-3302, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gierczynski, R., Golubov, A., Neubauer, H., Pham, J. N., Rakin, A.
(2007). Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Yersinia enterocolitica subsp. palearctica and Its Application to Bioserogroup 4/O3 Subtyping. J. Clin. Microbiol.
45: 2508-2515
[Abstract]
[Full Text]
-
Falcao, J. P., Falcao, D. P., Pitondo-Silva, A., Malaspina, A. C., Brocchi, M.
(2006). Molecular typing and virulence markers of Yersinia enterocolitica strains from human, animal and food origins isolated between 1968 and 2000 in Brazil.. J Med Microbiol
55: 1539-1548
[Abstract]
[Full Text]
-
Fearnley, C., On, S. L. W., Kokotovic, B., Manning, G., Cheasty, T., Newell, D. G.
(2005). Application of Fluorescent Amplified Fragment Length Polymorphism for Comparison of Human and Animal Isolates of Yersinia enterocolitica. Appl. Environ. Microbiol.
71: 4960-4965
[Abstract]
[Full Text]
-
Kotetishvili, M., Kreger, A., Wauters, G., Morris, J. G. Jr., Sulakvelidze, A., Stine, O. C.
(2005). Multilocus Sequence Typing for Studying Genetic Relationships among Yersinia Species. J. Clin. Microbiol.
43: 2674-2684
[Abstract]
[Full Text]
-
Healy, M., Huong, J., Bittner, T., Lising, M., Frye, S., Raza, S., Schrock, R., Manry, J., Renwick, A., Nieto, R., Woods, C., Versalovic, J., Lupski, J. R.
(2005). Microbial DNA Typing by Automated Repetitive-Sequence-Based PCR. J. Clin. Microbiol.
43: 199-207
[Abstract]
[Full Text]
-
Sanchez-Cespedes, J., Navia, M. M., Martinez, R., Orden, B., Millan, R., Ruiz, J., Vila, J.
(2003). Clonal Dissemination of Yersinia enterocolitica Strains with Various Susceptibilities to Nalidixic Acid. J. Clin. Microbiol.
41: 1769-1771
[Abstract]
[Full Text]
-
Soto, S. M., Lobato, M. J., Mendoza, M. C.
(2003). Class 1 Integron-Borne Gene Cassettes in Multidrug-Resistant Yersinia enterocolitica Strains of Different Phenotypic and Genetic Types. Antimicrob. Agents Chemother.
47: 421-426
[Abstract]
[Full Text]
-
STOCK, I., HEISIG, P., WIEDEMANN, B.
(2000). {beta}-Lactamase expression in Yersinia enterocolitica biovars 1A, 1B and 3. J Med Microbiol
49: 403-408
[Abstract]
[Full Text]